We’re tackling clinical problems (trial and error medicine) where epigenetics appears to be involved, namely: Infertility, Autoimmune Disease, Autism, and now COVID-19 disease severity and treatment response.
Our IP portfolio focuses on the use of epigenetic biomarkers for precision medicine and includes: exclusive licenses from the University of Utah, Washington State Univ. and assignment of the Skinner 8,586,307 Patent.